Home » New England Journal of...

You Searched For "New England Journal of Medicine"

We are what scientists call mosaics - bunches of cells that may have different genotypes buried deep within us. (Photo: Pixabay)

A new weapon against epilepsy

We are what scientists call mosaics - bunches of cells that may have different genotypes buried deep within us.

28 April 2018 9:01 AM

Representational Image. (AP)

Blood pressure medicines don't raise COVID-19 risk: Research

There had been concern arising from animal studies that these drugs might increase body's protein levels which the...

3 May 2020 5:54 AM

Representational Image. (AFP)

Blood type could determine your COVID-19 risk: Study

Type A blood were more likely to have severe disease while those with Type O were less likely

18 Jun 2020 7:15 AM

Smokers are charged higher premiums by employers, this entitles them to programs that will help them quit smoking at the same time. (Photo: Pixabay)

E-cigarettes disappoint in a workplace quit-smoking study

In a large study of company wellness programs, e-cigarettes worked no better than traditional stop-smoking tools.

24 May 2018 6:47 AM

When a trained pharmacist met men regularly at their local Los Angeles barbershop, clients were able to lower their blood pressure. (Photo: Pixabay)

Black barbershops can help clients lower blood pressure: study

High blood pressure is a chronic illness that requires a lifetime commitment to medication and lifestyle modification.

13 March 2018 3:59 AM

Scientists have developed a human cell culture model for schwannoma. (Photo: www.visualphotos.com)

Science Says: What happens when researchers make mistakes

Retractions are definitely on the riseâ€ and there are 10 times as many corrections as retractions.

14 Jun 2018 1:14 PM

Certain protease inhibitors, among the most effective HIV drugs, lead to the production of the peptide beta amyloid, often associated with Alzheimers disease. (Photo: AFP)

New HIV drug cuts viral load, boosts immunity: Study

Ibalizumab is a drug that targets the primary receptor for HIV entry into immune cells known as CD4 T cells.

16 Aug 2018 1:07 PM

In this March 2020 photo provided by Gilead Sciences, rubber stoppers are placed onto filled vials of the investigational drug remdesivir at a Gilead manufacturing site in the United States. Given through an IV, the medication is designed to interfere with an enzyme that reproduces viral genetic material. (Photo | AP)

WHO Solidarity trial testing antiviral drug remdesivir, as it could...

In an observational study, 68 per cent or two out of three patients after treatment with the drug did not require...

14 April 2020 8:21 AM

Hemophilia almost always strikes males and is caused by lack of a gene that makes a protein needed for blood to clot. (Photo: Pixabay)

Gene therapy shows promise against blood-clotting disease

Small cuts or bruises can be life-threatening, and many people need treatments once or more a week to prevent serious...

7 Dec 2017 8:07 AM